Zachary Jonathan Ward, M.P.H.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Maternal Mortality | 2 | 2023 | 300 | 1.410 |
Why?
|
Computer Simulation | 10 | 2024 | 6218 | 1.120 |
Why?
|
Obesity | 11 | 2024 | 12922 | 0.950 |
Why?
|
Body Height | 2 | 2022 | 1570 | 0.880 |
Why?
|
Delivery of Health Care | 5 | 2023 | 5325 | 0.870 |
Why?
|
Neoplasms | 13 | 2024 | 22072 | 0.720 |
Why?
|
Body Mass Index | 14 | 2024 | 12914 | 0.680 |
Why?
|
Obesity, Morbid | 5 | 2023 | 1287 | 0.620 |
Why?
|
Survival Analysis | 2 | 2020 | 10182 | 0.580 |
Why?
|
Developing Countries | 7 | 2024 | 2868 | 0.550 |
Why?
|
Health Care Costs | 7 | 2021 | 3258 | 0.530 |
Why?
|
Cost-Benefit Analysis | 19 | 2024 | 5508 | 0.530 |
Why?
|
Health Priorities | 1 | 2019 | 374 | 0.530 |
Why?
|
Growth | 1 | 2017 | 365 | 0.520 |
Why?
|
Health Services | 1 | 2021 | 753 | 0.510 |
Why?
|
Health Policy | 4 | 2024 | 2677 | 0.500 |
Why?
|
Taxes | 5 | 2023 | 222 | 0.440 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2020 | 2003 | 0.380 |
Why?
|
Body Weight | 2 | 2022 | 4611 | 0.370 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2022 | 3455 | 0.370 |
Why?
|
Drugs, Essential | 2 | 2021 | 70 | 0.350 |
Why?
|
Forecasting | 4 | 2023 | 2932 | 0.340 |
Why?
|
Health Services Accessibility | 4 | 2021 | 5397 | 0.330 |
Why?
|
Health Expenditures | 2 | 2021 | 2362 | 0.320 |
Why?
|
School Health Services | 4 | 2023 | 382 | 0.310 |
Why?
|
Self Report | 5 | 2023 | 3711 | 0.310 |
Why?
|
Child | 28 | 2024 | 79806 | 0.300 |
Why?
|
Developed Countries | 2 | 2020 | 442 | 0.290 |
Why?
|
Weight Loss | 1 | 2019 | 2686 | 0.290 |
Why?
|
Survival Rate | 4 | 2024 | 12808 | 0.290 |
Why?
|
Adolescent | 20 | 2024 | 87810 | 0.270 |
Why?
|
Models, Statistical | 4 | 2021 | 5075 | 0.250 |
Why?
|
Quality of Life | 3 | 2024 | 13308 | 0.250 |
Why?
|
Humans | 59 | 2024 | 760621 | 0.240 |
Why?
|
Sex Distribution | 2 | 2019 | 2295 | 0.230 |
Why?
|
Prevalence | 7 | 2023 | 15687 | 0.230 |
Why?
|
Income | 3 | 2023 | 1875 | 0.220 |
Why?
|
Bayes Theorem | 3 | 2019 | 2326 | 0.210 |
Why?
|
Stomach Neoplasms | 3 | 2021 | 1423 | 0.200 |
Why?
|
Female | 28 | 2024 | 391270 | 0.200 |
Why?
|
United States | 18 | 2024 | 72461 | 0.200 |
Why?
|
Child, Preschool | 12 | 2024 | 42063 | 0.200 |
Why?
|
Marketing | 1 | 2023 | 220 | 0.190 |
Why?
|
Health Promotion | 3 | 2019 | 2206 | 0.180 |
Why?
|
Incidence | 5 | 2024 | 21392 | 0.180 |
Why?
|
Chile | 1 | 2021 | 255 | 0.180 |
Why?
|
Nutrition Surveys | 4 | 2023 | 1725 | 0.180 |
Why?
|
Hepatitis B virus | 1 | 2024 | 522 | 0.180 |
Why?
|
Beverages | 4 | 2023 | 820 | 0.170 |
Why?
|
Health Status | 2 | 2024 | 4081 | 0.170 |
Why?
|
Policy | 1 | 2023 | 511 | 0.160 |
Why?
|
Nutrition Policy | 2 | 2020 | 470 | 0.160 |
Why?
|
Adult | 19 | 2024 | 219994 | 0.150 |
Why?
|
Public Health | 3 | 2022 | 2653 | 0.150 |
Why?
|
Male | 22 | 2024 | 359744 | 0.150 |
Why?
|
Uncertainty | 1 | 2023 | 754 | 0.150 |
Why?
|
Child Care | 2 | 2016 | 121 | 0.150 |
Why?
|
Nuclear Medicine | 1 | 2021 | 236 | 0.150 |
Why?
|
Young Adult | 10 | 2024 | 58741 | 0.150 |
Why?
|
Delayed Diagnosis | 1 | 2021 | 464 | 0.140 |
Why?
|
Food Services | 1 | 2020 | 205 | 0.140 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2017 | 146 | 0.140 |
Why?
|
Diagnostic Imaging | 2 | 2021 | 3527 | 0.140 |
Why?
|
Models, Theoretical | 2 | 2020 | 3562 | 0.140 |
Why?
|
Infant Care | 1 | 2017 | 180 | 0.130 |
Why?
|
Markov Chains | 1 | 2019 | 968 | 0.130 |
Why?
|
Internationality | 1 | 2021 | 1004 | 0.130 |
Why?
|
Europe | 1 | 2022 | 3441 | 0.130 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3388 | 0.130 |
Why?
|
Pepsinogen A | 1 | 2015 | 13 | 0.130 |
Why?
|
Islets of Langerhans | 1 | 2022 | 1345 | 0.130 |
Why?
|
Policy Making | 2 | 2016 | 538 | 0.120 |
Why?
|
Models, Economic | 2 | 2019 | 719 | 0.120 |
Why?
|
Physical Education and Training | 1 | 2015 | 100 | 0.120 |
Why?
|
Infant | 7 | 2024 | 36060 | 0.120 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2016 | 208 | 0.120 |
Why?
|
Immunization Programs | 1 | 2017 | 268 | 0.120 |
Why?
|
Age Factors | 2 | 2024 | 18416 | 0.110 |
Why?
|
Breast Neoplasms | 1 | 2021 | 21025 | 0.110 |
Why?
|
Age Distribution | 1 | 2019 | 2893 | 0.110 |
Why?
|
Gastroscopy | 1 | 2015 | 209 | 0.110 |
Why?
|
Helicobacter pylori | 2 | 2015 | 377 | 0.110 |
Why?
|
Water | 1 | 2019 | 1407 | 0.110 |
Why?
|
Helicobacter Infections | 2 | 2015 | 386 | 0.110 |
Why?
|
Life Expectancy | 1 | 2020 | 1248 | 0.110 |
Why?
|
Sweetening Agents | 1 | 2015 | 290 | 0.100 |
Why?
|
Statistics as Topic | 1 | 2019 | 2362 | 0.100 |
Why?
|
Mass Screening | 2 | 2021 | 5423 | 0.100 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 2943 | 0.100 |
Why?
|
Electronic Health Records | 2 | 2021 | 4775 | 0.100 |
Why?
|
Siblings | 1 | 2016 | 824 | 0.100 |
Why?
|
Mortality | 1 | 2023 | 2916 | 0.100 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 1547 | 0.100 |
Why?
|
Food | 3 | 2024 | 771 | 0.100 |
Why?
|
Quality-Adjusted Life Years | 4 | 2022 | 1724 | 0.090 |
Why?
|
Sex Factors | 1 | 2024 | 10547 | 0.090 |
Why?
|
Television | 3 | 2021 | 409 | 0.090 |
Why?
|
Reference Values | 1 | 2017 | 4925 | 0.090 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8552 | 0.080 |
Why?
|
Cause of Death | 1 | 2019 | 3725 | 0.080 |
Why?
|
Middle Aged | 10 | 2024 | 220352 | 0.080 |
Why?
|
Aged | 7 | 2024 | 169152 | 0.080 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13630 | 0.070 |
Why?
|
Databases, Factual | 2 | 2021 | 8035 | 0.070 |
Why?
|
Ultrasonography | 1 | 2020 | 5961 | 0.070 |
Why?
|
Adenocarcinoma | 2 | 2015 | 6315 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3202 | 0.070 |
Why?
|
Quality of Health Care | 1 | 2021 | 4360 | 0.070 |
Why?
|
Infant, Newborn | 3 | 2023 | 26181 | 0.060 |
Why?
|
Risk | 1 | 2017 | 9631 | 0.060 |
Why?
|
Survivors | 1 | 2016 | 2375 | 0.060 |
Why?
|
Cost of Illness | 3 | 2021 | 1940 | 0.060 |
Why?
|
Exercise | 2 | 2023 | 5787 | 0.060 |
Why?
|
Gambia | 1 | 2024 | 104 | 0.060 |
Why?
|
Africa, Western | 1 | 2024 | 159 | 0.060 |
Why?
|
Cohort Studies | 4 | 2019 | 41335 | 0.060 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 25942 | 0.050 |
Why?
|
Drug Costs | 2 | 2021 | 1185 | 0.050 |
Why?
|
Medicaid | 1 | 2015 | 2815 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 3986 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14495 | 0.050 |
Why?
|
Fast Foods | 1 | 2023 | 210 | 0.050 |
Why?
|
Chronic Disease | 1 | 2016 | 9287 | 0.050 |
Why?
|
Glutamate Decarboxylase | 1 | 2022 | 239 | 0.050 |
Why?
|
Food Labeling | 1 | 2023 | 180 | 0.050 |
Why?
|
Restaurants | 1 | 2023 | 230 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2021 | 58995 | 0.040 |
Why?
|
Prognosis | 1 | 2021 | 29658 | 0.040 |
Why?
|
Thailand | 1 | 2020 | 289 | 0.040 |
Why?
|
Smoking | 2 | 2015 | 9073 | 0.040 |
Why?
|
Schools | 2 | 2020 | 1480 | 0.040 |
Why?
|
Maine | 1 | 2019 | 145 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39261 | 0.040 |
Why?
|
California | 1 | 2023 | 1416 | 0.040 |
Why?
|
Benin | 1 | 2017 | 11 | 0.040 |
Why?
|
Moldova | 1 | 2017 | 14 | 0.040 |
Why?
|
Honduras | 1 | 2017 | 37 | 0.040 |
Why?
|
Mexico | 1 | 2019 | 760 | 0.040 |
Why?
|
Zambia | 1 | 2017 | 257 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20509 | 0.030 |
Why?
|
Ghana | 1 | 2017 | 312 | 0.030 |
Why?
|
Heart Failure | 1 | 2020 | 11847 | 0.030 |
Why?
|
Epidemics | 1 | 2021 | 510 | 0.030 |
Why?
|
Energy Intake | 1 | 2023 | 2129 | 0.030 |
Why?
|
Probability | 1 | 2021 | 2475 | 0.030 |
Why?
|
China | 1 | 2021 | 2339 | 0.030 |
Why?
|
Models, Cardiovascular | 1 | 2020 | 978 | 0.030 |
Why?
|
Autoantibodies | 1 | 2022 | 2118 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36290 | 0.030 |
Why?
|
Uganda | 1 | 2017 | 1324 | 0.030 |
Why?
|
State Government | 1 | 2015 | 380 | 0.030 |
Why?
|
Health Facilities | 1 | 2017 | 578 | 0.030 |
Why?
|
Overweight | 1 | 2023 | 2421 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3618 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2020 | 2007 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2024 | 3061 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2016 | 2932 | 0.020 |
Why?
|
Radiography | 1 | 2021 | 6965 | 0.020 |
Why?
|
Poverty | 1 | 2021 | 2695 | 0.020 |
Why?
|
Regression Analysis | 1 | 2017 | 6360 | 0.020 |
Why?
|
Echocardiography | 1 | 2020 | 4981 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2013 | 1109 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14660 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2020 | 6465 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7475 | 0.010 |
Why?
|
Parents | 1 | 2016 | 3549 | 0.010 |
Why?
|
Decision Making | 1 | 2016 | 3925 | 0.010 |
Why?
|
Smoking Cessation | 1 | 2013 | 2064 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7818 | 0.010 |
Why?
|
Primary Health Care | 1 | 2016 | 4647 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2016 | 22053 | 0.010 |
Why?
|
Risk Assessment | 1 | 2013 | 24123 | 0.010 |
Why?
|
Time Factors | 1 | 2013 | 40165 | 0.010 |
Why?
|
Risk Factors | 1 | 2013 | 74359 | 0.000 |
Why?
|